Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Tax Provisions: 2009-2025

Historic Tax Provisions for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to $1.2 million.

  • Myriad Genetics' Tax Provisions rose 33.33% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.8 million, marking a year-over-year decrease of 4033.33%. This contributed to the annual value of $3.8 million for FY2024, which is 245.45% up from last year.
  • Myriad Genetics' Tax Provisions amounted to $1.2 million in Q3 2025, which was up 1,300.00% from -$100,000 recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Tax Provisions ranged from a high of $15.2 million in Q3 2021 and a low of -$35.9 million during Q4 2021.
  • Over the past 3 years, Myriad Genetics' median Tax Provisions value was $100,000 (recorded in 2024), while the average stood at -$2.3 million.
  • Per our database at Business Quant, Myriad Genetics' Tax Provisions surged by 800.00% in 2024 and then tumbled by 29,400.00% in 2025.
  • Quarterly analysis of 5 years shows Myriad Genetics' Tax Provisions stood at -$35.9 million in 2021, then skyrocketed by 72.70% to -$9.8 million in 2022, then skyrocketed by 88.78% to -$1.1 million in 2023, then surged by 409.09% to $3.4 million in 2024, then skyrocketed by 33.33% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, -$100,000 for Q2 2025, and -$29.3 million during Q1 2025.